InvestorsHub Logo
Followers 53
Posts 9888
Boards Moderated 1
Alias Born 10/06/2005

Re: janeyH post# 174

Friday, 09/13/2019 11:03:02 AM

Friday, September 13, 2019 11:03:02 AM

Post# of 1668
I GRABBED MORE. Think this is significent:
Profound is also commercializing Sonalleve(R), an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve(R) has also been approved by the China Food and Drug Administration for the non-invasive treatment of uterine fibroids. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve(R) where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.

Remembering how long I sat with TPNL waiting, accumulating, and waiting more. Now, that patience has provided the ability to accumulate size here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PROF News